Share Name |
Share Symbol |
Market |
Type |
Share ISIN |
Share Description |
Skinbiotherapeutics Plc |
LSE:SBTX |
London |
Ordinary Share |
GB00BF33H870 |
ORD 1P |
|
Price Change |
% Change |
Share Price |
Bid Price |
Offer Price |
High Price |
Low Price |
Open Price |
Shares Traded |
Last Trade |
|
0.00 |
0.0% |
29.00 |
29.00 |
29.50 |
31.00 |
29.25 |
29.75 |
1,390,164 |
16:35:11 |
Industry Sector |
Turnover (m) |
Profit (m) |
EPS - Basic |
PE Ratio |
Market Cap (m) |
Pharmaceuticals & Biotechnology |
0.0 |
-1.6 |
-1.2 |
- |
45 |
Skinbiotherapeutics Share Discussion Threads

Showing 7526 to 7548 of 8575 messages
Date | Subject | Author | Discuss |
---|
26/8/2020 16:48 | Agreed. We also have confirmed medium term buying pressure. Who is to say that will not turn onto long term buying pressure? (up-trend) |  pj 1 | |
26/8/2020 16:35 | Couldn’t resist
What about cleanbiotix and woundcare?
Cleanbiotix quote has 3 times as many companies at the table as it did pre covid and a quote again it’s a race between the 2 as to which one gets over the line first.
A lot more going on here than just sederma and winclove.
S |  shrewdmole | |
26/8/2020 15:12 | Gary, you must keep your day trading money separate from your investment pot and then the short term wait becomes irrelevant. We have been told that start of next year the oral treatment for psoriasis will commence (expect the announcement in Dec 20), at which point the share price will re-rate. In the interim, the only possible news is an announcement that a partnership has been formed for the Medical Device Skin care / enhancing barrier workstream, which would also advance the share price but equally may not arrive this year. So, investing money now, that you do not need to touch is a no-brainer, and getting impatient prior to the known trial news Dec/Jan is illogical |  aquaesulis01 | |
26/8/2020 15:08 | How does that get a tick down?
Only said it as it’s posted as a sell..
Time to avoid the boards again for a bit. |  shrewdmole | |
26/8/2020 11:56 | 20k at 22.625p is a buy |  shrewdmole | |
26/8/2020 11:33 | As long as you are not too heavily overloaded to the point of worrying, try to let it run it's course Gary. A retrace was always on the cards (AIM guarantee virtually!) but I think at some point this will burst through to a new high and might not retrace again to these kinds of level. I share your appetite for further exciting news though! |  lovewinshatelosses | |
26/8/2020 11:06 | Just the impatient side of me coming out? |  gary hindsight | |
26/8/2020 11:04 | Mad, totally agree with you, progress for sure has been made. I guess we all know at some point there will be some news that makes a material difference and it's about when. It's just the disappointment each morning that it's not today. |  gary hindsight | |
26/8/2020 10:18 | I personally think we have seen enormous progress from SBTX since SA arrival. It is easy to forget that they have so few staff to deliver such high expectations but I for one am happy to hold as I see steady and assured progress in all that they do. OPTI has been a longer burn for me but am still confident in the team in place. IMHO DYOR GLA |  madaboutmed | |
26/8/2020 09:56 | Trouble is I wake up every day before 7am waiting for rns on sweetbiotix for opti or new deal for sbtx to set them alight. Trouble is pretty much every day at 7:01 I am disappointed. One day I will be happy I just don't know when |  gary hindsight | |
26/8/2020 08:14 | There’s a lot of impatience about, more so at Opti but I just think this sector is only just waking up.
Some of us were in very very early in Opti so it feels like forever.
Taking a step back now and with the sector starting to be accepted and the science in a more mainstream fashion and this still is the start of what could be a huge sector.
Seres, now 4d and big globals signing up as partners.
Shrewdie |  shrewdmole | |
26/8/2020 08:07 | Positive results out of Microbiome company 4D this morning following on from recent good news out of Seres.Bodes well for the whole Microbiome sector. SBTX and OPTI should benefit. |  parob | |
25/8/2020 10:05 | semp,
😂🤣 |  judijudi | |
25/8/2020 10:04 | toyin,
Cool 👌 |  judijudi | |
25/8/2020 09:55 | I buy and it causes a dip! |  semper vigilans | |
25/8/2020 09:53 | But you are arguing, you are the one that started the criticism.
"Mind" and "like" are two different things.
I dont like them, I would much sooner it goes up in a steady line, but that isn't reality. The reality is we have dips, so I use them as an opportunity to add to my position. |  toyin | |
25/8/2020 09:46 | Anyway I’m not arguing
All I’m saying is that you have both got what you wanted. Another top up opportunity
Me I don’t want them or like them
As a holder I like rises
I like the selling opportunities (not that I would)
Had enough years of top up opportunities myself
Only my humble opinion of course |  judijudi | |
25/8/2020 09:44 | toyin,
“I always buy the dips so I dont mind a pull back”
madabout
“Wholly agree. More opportunities to top up” |  judijudi | |
25/8/2020 09:39 | Judi, when did I say I liked the drops? Nothing goes up in a straight line so the drops are part of the game, what is so difficult to understand about that? I dont feel sarcasms and criticism is warranted.
On a different note.
https://primefeed.in/news/4662534/why-skin-microbiome-market-fastest-growth-segment-should-surprise-us-profiling-key-players-azitra-bayer-ag-s-biomedic-skinbiotherapeutics-plc-matrisys-bioscience-aobiome-dermbiont-inc-naked/ |  toyin | |
25/8/2020 09:29 | Why 🤷a94;️
Those lads like the drops, they’ve said as much
toyin24 Aug '20 - 16:51 - 6502 of 6509
Whatever it is the story hasn't changed, I always buy the dips so I dont mind a pull back.
madaboutmed24 Aug '20 - 17:01 - 6503 of 6509
Wholly agree. More opportunities to top up. |  judijudi | |
25/8/2020 09:18 | How childish |  madaboutmed | |
25/8/2020 09:02 | toyin/mad,
Get buying
Another top up opportunity for you both
You must be ecstatic |  judijudi | |
25/8/2020 08:56 | Good point Gary and noted |  ramas | |